{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:23:17Z","timestamp":1790950997729,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.14283\/jpad.2024.41","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T10:29:29Z","timestamp":1707388169000},"page":"639-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Who Benefited Most from the Internet-Based Conversational Engagement RCT (I-CONECT)? Application of the Personalized Medicine Approach to a Behavioral Intervention Study"],"prefix":"10.1016","volume":"11","author":[{"given":"Chao-Yi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.41_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.14283\/jpad.2024.41_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.14283\/jpad.2024.41_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/01621459.2013.770705","article-title":"Effectively selecting a target population for a future comparative study","volume":"108","author":"Zhao","year":"2013","journal-title":"J Am Stat Assoc"},{"key":"10.14283\/jpad.2024.41_bib4","first-page":"1","article-title":"Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease","author":"Pang","year":"2023","journal-title":"Alzheimer's & Dementia"},{"key":"10.14283\/jpad.2024.41_bib5","doi-asserted-by":"crossref","first-page":"e12220","DOI":"10.1002\/trc2.12220","article-title":"Reproducibility and replicability of high-frequency, in-home digital biomarkers in reducing sample sizes for clinical trials","volume":"7","author":"Wu","year":"2021","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.14283\/jpad.2024.41_bib6","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Enrichment strategies for clinical trials to support approval of human drugs and biological products guidance for industry. Silver Spring, MD (2019)."},{"key":"10.14283\/jpad.2024.41_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bimj.200900003","article-title":"Adaptive patient enrichment designs in therapeutic trials","volume":"51","author":"Wang","year":"2009","journal-title":"Biometrical Journal: Journal of Mathematical Methods in Biosciences"},{"key":"10.14283\/jpad.2024.41_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.14283\/jpad.2024.41_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1745-6215-8-31","article-title":"Responder analyses and the assessment of a clinically relevant treatment effect","volume":"8","author":"Snapinn","year":"2007","journal-title":"Trials"},{"key":"10.14283\/jpad.2024.41_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cct.2008.02.002","article-title":"Do \u201cplacebo responders\u201d exist?","volume":"29","author":"Kaptchuk","year":"2008","journal-title":"Contemporary Clinical Trials"},{"key":"10.14283\/jpad.2024.41_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.csda.2004.11.015","article-title":"Responder identification in clinical trials with censored data","volume":"50","author":"Kehl","year":"2006","journal-title":"Computational Statistics & Data Analysis"},{"key":"10.14283\/jpad.2024.41_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trci.2015.01.001","article-title":"Web-enabled conversational interactions as a method to improve cognitive functions: Results of a 6-week randomized controlled trial","volume":"1","author":"Dodge","year":"2015","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.14283\/jpad.2024.41_bib13","article-title":"Internet-based conversational engagement randomized controlled clinical trial (I-CONECT) among socially isolated adults 75+ years old with normal cognition or mild cognitive impairment: Topline results","author":"Dodge","year":"2023","journal-title":"The Gerontologist"},{"key":"10.14283\/jpad.2024.41_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.14283\/jpad.2024.41_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1017\/S1355617700677032","article-title":"Category Fluency Test: Normative data for English- and Spanish-speaking elderly","volume":"6","author":"Acevedo","year":"2000","journal-title":"Journal of the International Neuropsychological Society"},{"key":"10.14283\/jpad.2024.41_bib16","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1002\/sim.9581","article-title":"Progression models for repeated measures: Estimating novel treatment effects in progressive diseases","volume":"41","author":"Raket","year":"2022","journal-title":"Statistics in Medicine"},{"key":"10.14283\/jpad.2024.41_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fdgth.2021.714813","article-title":"The Internet-based conversational engagement clinical trial (I-CONECT) in socially isolated adults 75+ years old: Randomized controlled trial protocol and COVID-19 related study modifications","volume":"3","author":"Yu","year":"2021","journal-title":"Frontiers in Digital Health"},{"key":"10.14283\/jpad.2024.41_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1300\/J018v05n01_09","article-title":"Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version","volume":"5","author":"Sheikh","year":"1986","journal-title":"Clinical Gerontologist: The Journal of Aging and Mental Health"},{"key":"10.14283\/jpad.2024.41_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0191-8869(03)00118-1","article-title":"A contemplated revision of the NEO five-factor inventory","volume":"36","author":"McCrae","year":"2004","journal-title":"Personality and individual differences"},{"key":"10.14283\/jpad.2024.41_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jgs.17607","article-title":"Can changes in social contact (frequency and mode) mitigate low mood before and during the COVID-19 pandemic? The I-CONECT project","volume":"70","author":"Wu","year":"2022","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.14283\/jpad.2024.41_bib21","doi-asserted-by":"crossref","first-page":"106584","DOI":"10.1016\/j.cmpb.2021.106584","article-title":"Explanation of machine learning models using shapley additive explanation and application for real data in hospital","volume":"214","author":"Nohara","year":"2022","journal-title":"Computer Methods and Programs in Biomedicine"},{"key":"10.14283\/jpad.2024.41_bib22","article-title":"Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Fran\u00e7ais de la Scl\u00e9rose en Plaques registry","volume":"8","author":"Simoneau","year":"2022","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.14283\/jpad.2024.41_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40120-022-00350-y","article-title":"Long-term health outcomes of Lecanemab in patients with early Alzheimer's disease using simulation modeling","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"key":"10.14283\/jpad.2024.41_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/fhep-2014-0013","article-title":"The value of delaying Alzheimer's disease onset","volume":"18","author":"Zissimopoulos","year":"2014","journal-title":"Forum Health Econ Policy"},{"key":"10.14283\/jpad.2024.41_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/joim.12178","article-title":"Advances in the prevention of Alzheimer's disease and dementia","volume":"275","author":"Solomon","year":"2014","journal-title":"Journal of Internal Medicine"},{"key":"10.14283\/jpad.2024.41_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14737167.2020.1822738","article-title":"Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease","volume":"20","author":"Gustavsson","year":"2020","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:08:12Z","timestamp":1737338892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2274580724000566"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.41","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Who Benefited Most from the Internet-Based Conversational Engagement RCT (I-CONECT)? Application of the Personalized Medicine Approach to a Behavioral Intervention Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.41","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}